![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1537, 2006-01, pp. : 20-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oral, not transdermal, estrogens raise thromboembolism risk
Reactions Weekly, Vol. 1, Iss. 1291, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oral HRT doubles venous thromboembolism risk
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Hormonal contraceptive use appears to reduce bacterial vaginosis risk
Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bevacizumab: increased risk of venous thromboembolism
Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bevacizumab: increased risk of venous thromboembolism
Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. :